Characterization of five 19-nor-analogs of 1alpha,25(OH)2-Vitamin D3 with 20-cyclopropyl-modified side-chains: implications for ligand binding and calcemic properties

The Journal of Steroid Biochemistry and Molecular Biology
Christopher J OliveraAnthony W Norman

Abstract

The steroid hormone 1alpha,25(OH)(2)-Vitamin D(3) [1alpha,25(OH)(2)D(3)] exerts a wide variety of biological actions through one or more receptors/binding proteins. The nuclear Vitamin D receptor (VDR) when bound to its natural ligand, 1alpha,25(OH)(2)D(3), can stimulate transcription of a wide variety of genes. The synthesis of 1alpha,25(OH)(2)D(3) analogs allows the study of structure-function relationships between ligand and the VDR. 1alpha,25(OH)(2)D(3) is a conformationally flexible molecule; specifically the side-chain of the hormone can display a large variety of shapes for its receptor. Here, we describe and analyze the properties of 10 1alpha,25(OH)(2)D(3) analogs modified at the side-chain of which five lack carbon-19 (19-nor) but have a novel 20-cyclopropyl functionality. Analog NG [20,21-methylene-23-yne-26,27-F(6)-19-nor-1alpha,25(OH)(2)D(3)] possesses a respectable binding affinity for the VDR and exhibits a high transcriptional activity (EC(50) approximately 10pM), while retaining low induction of hypercalcemia in vivo in the mouse, making it a primary candidate for further analyses of its anti-proliferative and/or cell differentiating properties.

References

Feb 6, 1992·The New England Journal of Medicine·M W TilyardS Dovey
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J Y ZhouH P Koeffler
Nov 2, 1972·The New England Journal of Medicine·A S BrickmanA W Norman
Aug 15, 1980·Science·A W NormanG M Grodsky
Aug 25, 1995·Biochemical Pharmacology·R BouillonH van Baelen
Aug 1, 1994·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·J E BishopA W Norman
Jan 19, 2000·The Prostate·W B Grant
Apr 3, 2002·Trends in Molecular Medicine·Chantal Mathieu, Luciano Adorini
Aug 22, 2002·International Immunopharmacology·Luciano Adorini
Sep 17, 2002·Urology·Candace S JohnsonDonald L Trump
Oct 26, 2002·Endocrinology·Vijaya VegesnaH Phillip Koeffler
Dec 24, 2002·Clinical Pharmacology and Therapeutics·Josephia R MuindiDonald L Trump
Aug 6, 2003·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·Anthony W NormanWilliam H Okamura
Jan 7, 2004·Nature Reviews. Drug Discovery·Anthony W NormanDerek P G Norman

❮ Previous
Next ❯

Citations

Mar 21, 2007·The Journal of Steroid Biochemistry and Molecular Biology·Mathew T MizwickiAnthony W Norman
Aug 6, 2005·The Journal of Steroid Biochemistry and Molecular Biology·Igor N Sergeev
Jul 7, 2011·International Journal of Cancer. Journal International Du Cancer·Ryoko OkamotoH Phillip Koeffler
Jun 22, 2013·ChemMedChem·Can-Fei ZhangZhao-Peng Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.